Table 2. Outcomes, clinical complications, and COVID-19 interventions.
| NHW | Black | Hispanic | AAPI | Other | All | |
|---|---|---|---|---|---|---|
| n** (%) | n** (%) | n** (%) | n** (%) | n** (%) | n** (%) | |
| Outcomes | ||||||
| Total all-cause mortality* | 60 (8) | 38 (13) | 12 (5) | <5(<11) | 9 (12) | 123 (9) |
| 30-day all-cause mortality† | 40 (5) | 29 (10) | 8 (3) | <5 (<11) | 8 (10) | 89 (6) |
| Received mechanical ventilation* | 24 (3) | 26 (9) | 11 (5) | <5 (<11) | <5 (<6) | 69 (5) |
| Admitted to an intensive care unit* | 45 (6) | 31 (11) | 18 (8) | 7 (16) | 10 (13) | 111 (8) |
| Admitted to the hospital* | 245 (33) | 137 (47) | 77 (33) | 20 (44) | 33 (42) | 512 (37) |
| Clinical complications | ||||||
| Any cardiovascular complication‡ | 82 (11) | 50 (17) | 30 (13) | 6 (13) | 18 (23) | 186 (14) |
| Any pulmonary complication§ | 170 (23) | 88 (31) | 43 (18) | 12 (27) | 23 (30) | 336 (24) |
| Any gastrointestinal complication¶ | 12 (2) | 7 (2) | <5 (<2) | <5 (<11) | <5 (<7) | 26 (2) |
| Acute kidney injury | 41 (6) | 46 (16) | 11 (5) | 5 (11) | 10 (13) | 113 (8) |
| Multisystem organ failure | 10 (1) | 12 (4) | <5 (<2) | <5 (<11) | <5 (<7) | 29 (2) |
| Superimposed infection | 62 (9) | 42 (15) | 14 (6) | 7 (16) | <5 (<7) | 129 (10) |
| Sepsis | 43 (6) | 24 (8) | 15 (6) | 7 (16) | 12 (16) | 101 (7) |
| Any bleeding | 15 (2) | 7 (2) | <5 (<2) | <5 (<11) | <5 (<7) | 29 (2) |
| Interventions | ||||||
| Remdesivir | 68 (10) | 20 (7) | 15 (7) | 8 (18) | 5 (7) | 116 (9) |
| Hydroxychloroquine | 60 (9) | 41 (15) | 14 (6) | <5 (<11) | 11 (15) | 129 (10) |
| Systemic corticosteroids | 107 (15) | 50 (18) | 31 (14) | 8 (18) | 13 (18) | 209 (16) |
| Other | 112 (16) | 53 (19) | 36 (16) | 11 (25) | 12 (17) | 224 (17) |
| Supplemental oxygen | 173 (24) | 87 (31) | 43 (19) | 14 (31) | 24 (31) | 341 (25) |
Variable categories with one to five cases are masked by replacing with N<5 according to CCC19 policy.
Included in primary outcome.
Secondary outcome.
Cardiovascular complication includes hypotension, myocardial infarction, other cardiac ischemia, atrial fibrillation, ventricular fibrillation, other cardiac arrhythmia, cardiomyopathy, congestive heart failure, pulmonary embolism (PE), deep vein thrombosis (DVT), stroke, thrombosis NOS complication.
Pulmonary complication includes respiratory failure, pneumonitis, pneumonia, acute respiratory distress syndrome (ARDS), PE, pleural effusion, empyema.
Gastrointestinal complication includes acute hepatic injury, ascites, bowel obstruction, bowel perforation, ileus, peritonitis.
N based on number of patients with non-missing data.